Current understanding of insulin resistance in hepatitis C. - Wikidata - awgldk - TriplyDB

Current understanding of insulin resistance in hepatitis C.

Current understanding of insulin resistance in hepatitis C.

http://www.wikidata.org/entity/Q37903853

about

Modulation of triglyceride and cholesterol ester synthesis impairs assembly of infectious hepatitis C virus.Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis.Hepatitis C virus diversity and hepatic steatosis.Hepatitis C virus induces a prediabetic state by directly impairing hepatic glucose metabolism in mice.Hepatitis C virus infection triggers a tumor-like glutamine metabolism.Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study.HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients.SIGNIFICANT IMPROVEMENT OF GLYCAEMIC CONTROL IN DIABETIC PATIENTS WITH HCV INFECTION RESPONDING TO DIRECT-ACTING ANTIVIRAL AGENTS.Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: a nationwide cohort study.A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy

P2860

Q33985223-8412D0C1-A6D3-4490-812B-0EAA7B70B80A Q38040323-149EC7F5-4208-4970-B073-576EE0771C6D Q38072721-FAEEC929-3ADA-4078-BBB4-135F3FF61C18 Q38701810-2DC57D46-4843-4E1D-A233-D2290FB621B8 Q39174025-1F1C5707-47D1-426A-8E0E-12AF1370CFDD Q40695544-CD9AC741-E96A-4EA9-8D11-4D62B061514B Q41528078-8BC0A0E2-2242-4902-97CA-1CA2E6D96352 Q41928201-2ED113C2-5FD5-4DD3-93C1-8C5505EB267A Q42213082-DF67EF13-CA67-4814-884C-C8B8D02FDFEF Q57173478-90A3432D-64FA-43AA-9585-67A321FE34A0 Q58785077-0B4092A2-68DD-4A30-9CE6-B3B0605A37CD

P2860

Current understanding of insulin resistance in hepatitis C.

http://www.wikidata.org/entity/Q37903853

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Current understanding of insulin resistance in hepatitis C.

@en

Current understanding of insulin resistance in hepatitis C.

@nl

type

label

Current understanding of insulin resistance in hepatitis C.

@en

Current understanding of insulin resistance in hepatitis C.

@nl

prefLabel

Current understanding of insulin resistance in hepatitis C.

@en

Current understanding of insulin resistance in hepatitis C.

@nl

P1433

Q37903853-DCBBBA54-F645-4152-BE99-7E673D81FD5C

P1476

Q37903853-F5F3CA41-35E1-47CD-9724-5F4AE7F28FD1

P2093

Q37903853-5C37F7F4-9923-4222-BC2D-23C156A72287

Q37903853-B3AF1319-EBE6-4321-8E0D-692929FBD6F3

P2860

Q37903853-02B947B6-3F22-4C86-8C6E-9BE502EC6158

Q37903853-05C574F8-F1D0-4AA5-A5D3-09080276BC18

Q37903853-06DA409D-550A-44C1-8D67-44F4C8307AA7

Q37903853-081A9DA5-0E40-48E4-A0A5-7B1E9A18FD23

Q37903853-0C94DE56-2929-499A-8F36-FD2EFB33F5C4

Q37903853-0D6B9B28-CEE5-4B04-9612-8F4BCD18802E

Q37903853-0DA37C0E-F2E9-41CC-A5B1-87F430503F57

Q37903853-0E116441-2C9C-4FC2-81BB-F09ADDB033C0

Q37903853-0F1BC102-4D7F-47B6-9EB1-F791AD6F066B

Q37903853-0FC0FD48-84C1-4908-9D52-CC353B59A76D

P304

Q37903853-277EE826-8BE3-4177-B065-9F472E541F94

P31

Q37903853-27FEAEED-F387-4F8D-B735-487780EF9681

P356

Q37903853-9FBCC397-F9E5-49AC-88BF-7F4717291348

P433

Q37903853-2B507531-638D-4B54-B0DA-495E41974820

P478

Q37903853-0465CBB9-1B36-4906-A2D9-514AE55CFA93

P577

Q37903853-A83F891E-02D2-41C5-AC21-F7A9271F9C15

P5875

Q37903853-07A0DF89-1994-42C0-B34B-8D9F916AF83A

P698

Q37903853-B50705F4-42BC-4E6F-A55F-C75AC905AE52

P921

Q37903853-C3ED2553-95DF-4537-A20B-365BCBB2E426

P356

P1433

Expert Review of Gastroenterology & Hepatology

P1476

Current understanding of insulin resistance in hepatitis C.

@en

P2093

Francesco Negro

http://www.w3.org/2001/XMLSchema#string

Vincent Kaddai

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease

A complex interplay between Akt, TSC2 and the two mTOR complexes

Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1.

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

Involvement of the PA28 -Dependent Pathway in Insulin Resistance Induced by Hepatitis C Virus Core Protein

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?

Positive and negative regulation of insulin signaling through IRS-1 phosphorylation

The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2

P304

503-516

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/EGH.11.43

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51513256

http://www.w3.org/2001/XMLSchema#string

P698

21780897

http://www.w3.org/2001/XMLSchema#string

P921